AERI
Aerie Pharmaceuticals, Inc.
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
172 hedge funds and large institutions have $2.33B invested in Aerie Pharmaceuticals, Inc. in 2018 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 70 increasing their positions, 53 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
172
Holders Change
-7
Holders Change %
-3.91%
% of All Funds
3.95%
Holding in Top 10
7
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-36.36%
% of All Funds
0.16%
New
18
Increased
70
Reduced
53
Closed
24
Calls
$15.7M
Puts
$21.5M
Net Calls
-$5.87M
Net Calls Change
-$24.7M
Top Buyers
| 1 |
HM
HealthCor Management
New York
|
+$65.1M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$39.4M |
| 3 |
O
OrbiMed
New York
|
+$30.1M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$29.1M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$25M |
